Skip to main content
. 2019 Dec 9;29(2):305–319. doi: 10.1093/hmg/ddz284

Figure 8.

Figure 8

Working model of how KMT2D may function to activate NC-specific enhancers. KMT2D deposits H3K4me1 marks at genomic targets. p300 interaction is mediated via the KMT2D/KDM6A complex, finally leading to H3K27 acetylation and a fully active enhancer state.